MLchartDataset catalogue

autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine

Term · Oncology and biomedicine · MLC-T-ONC-011622

A cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV) in vitro with potential immunoprotective activity. Upon prophylactic administration, this vaccine may stimulate specific cytotoxic T-lymphocyte (CTL) and antibody responses against EBV-transformed B cells, thereby preventing an EBV-induced post-transplantation lymphoproliferative disorder.

Table 1. Record
IdentifierMLC-T-ONC-011622
FieldOncology and biomedicine
Synonymsautologous EBV-transformed B-lymphoblastoid cell vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011622",
  "term": "autologous Epstein-Barr virus-transformed B-lymphoblastoid cell vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cell-based vaccine composed of autologous lymphoblastoid B cells activated against Epstein-Barr virus (EBV) in vitro with potential immunoprotective activity. Upon prophylactic administration, this vaccine may stimulate specific cytotoxic T-lymphocyte (CTL) and antibody responses against EBV-transformed B cells, thereby preventing an EBV-induced post-transplantation lymphoproliferative disorder.",
  "synonyms": [
    "autologous EBV-transformed B-lymphoblastoid cell vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-epstein-barr-virus-transformed-b-lymphoblastoid-cell-vaccine/"
}

Record 2,956 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.